$DSM

Barclays analyst Lauren Lieberman said the fine fragrance market remains strong and is growing more normalized after prior double-digit gains. Takasago attributed progress to global growth and expects continued strength in China and Southeast Asia. Supplier updates showed IFF low-single-digit fine fragrance growth, DSM-Firmenich double-digit like-for-like H1 gains, Givaudan 7.3% like-for-like H1, and Symrise midsingle-digit Q2 decline. Takasago reported FY26-27 Q1 overall sales up 14.3% to 65.81

DSM-Firmenich said it will cut up to 1,000 jobs over 18 to 24 months after selling its Animal Nutrition & Health division to CVC Capital Partners for about €2.2 billion, plus up to €500 million earnout. The company expects €100 million annualized cost savings and a one-off €100 million charge. H1 2026 core units grew, while ANH sales fell and margins dropped.

Skapyak Bradley J purchased 1,894 shares of BNY MELLON STRATEGIC MUNICIPAL BOND FUND, INC. (DSM) at $6.09 on 2026-06-08.

BNY Mellon Strategic Municipal Bond Fund (NYSE: DSM) reported short interest of 115,543 shares as of May 15, up 148.2% from 46,560 on April 30. With average daily volume of 79,442, the short-interest ratio is 1.5 days; 0.2% of shares are sold short. DSM shares fell 0.5% to $6.12. The fund also declared a $0.03 monthly dividend (record June 11, pay June 30).

dsm-firmenich announces redemption of €750 million hybrid bond Kaiseraugst ( Switzerland ) , Maastricht ( Netherlands ) , July 1, 2025